Partner, Andera Partners
Raphaël began his career in London, where he spent seven years in the healthcare and investment banking industries. He was first part of the finance department of Générale de Santé International in London, the largest private hospitals group in the UK. He subsequently worked in the healthcare groups of the Investment Banking divisions of Salomon Smith Barney and Goldman Sachs where he participated in many M&A and capital raising deals within pharmaceuticals, medical devices, biotechnology and services companies. Since joining Andera Partners in 2001 he has worked on several investments, IPOs and trade sales in the biotechnology and medical device sectors. He currently sits on the boards of ReViral, Poxel, Enyo Pharma, Artios Pharma, Grey Wolf Therapeutics, AM Pharma, Dynacure and Axonics.
Raphaël graduated from the French business school HEC in 1993 and received a Masters in Applied Economics from Institut d’Etudes Politiques in 1994.